Cigna's Express Scripts Sues Federal Trade Commission

"The FTC has taken unconstitutional actions in publishing a report that ignores the evidence provided by our company and other [pharmacy benefit managers], demonstrates clear ideological bias and advances a false and damaging narrative—narrative that could harm the health care system by removing essential checks and balances which would result in higher drug prices for American consumers," The Cigna Group Chief Legal Officer Andrea Nelson said.

September 17, 2024 at 04:38 PM

3 minute read

Litigation

By Emily Cousins
Litigation Reporter

The original version of this story was published on Law.com

Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission's July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent pharmacies—is false and misleading.

NOT FOR REPRINT